Arm Holdings plc American Depositary Shares
NASDAQ:ARMSemiconductors
+$13.02 today
- Market cap
- $195.55B
- Beta
- 3.79
- P/E (TTM)
- 507.4
- EPS (TTM)
- $0.85
Volume 4.33M
Average 12.00M
ARM Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Arm Holdings plc American Depositary SharesNASDAQ: ARM
Research & Development · Q1 FY2027 · quarter ended Jun 2026
Research & development grows, but more slowly than its trailing trend
Q1 FY2027 research & development of $838M rose 28.1% year over year, behind the +32.3% change in trailing-twelve-month research & development. Sequentially, it rose 20.1% from the prior quarter. Over 3 fiscal years it compounded at +37.0% a year.
Context
- Research & development amounted to 56.4% of revenue in FY2026, up 6.3 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +28.1% toward the trailing-twelve-month pace of +32.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 2.78B USD
- Year-over-year change
- +38.2%
- 4-year CAGR
- +30.9%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 2.78B | +38.2% |
| FY2025 | 2025-03-31 | 2.01B | +4.0% |
| FY2024 | 2024-03-31 | 1.93B | +78.9% |
| FY2023 | 2023-03-31 | 1.08B | +14.3% |
| FY2022 | 2022-03-31 | 945M | — |
Research & Development vs competitors
How ARM compares with its peers on the latest reported figures
- ARM's LTM Jun 2026 research & development of $2.96B is the highest of the 5 companies compared; the peer median is $1.2B.
- Its year-over-year change of +32.3% is the highest of 5, against a peer median of +16.4%.
- Research & development amounts to 57.5% of revenue for ARM, versus a peer median of 20.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.96B | +32.3% | +37.0% | 57.5% | |
| LTM Jul 2026 | $2.88B | +26.0% | +16.0% | 30.6% | |
| LTM Aug 2026 | $1.98B | +17.8% | +1.3% | 14.2% | |
| LTM Jun 2026 | $412.95M | +14.9% | +16.8% | 12.6% | |
| LTM Jun 2026 | $200.09M | +15.0% | +5.7% | 26.5% | |
| Peer median (excluding ARM) | $1.2B | +16.4% | +10.9% | 20.3% | |
Competitors are the stored peer set for ARM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 2.7B | 2.68B | 3.23B | 4.01B | 4.92B |
| Cost of Revenue | 220M | 195M | 234M | 206M | 370M |
| Gross Profit | 2.48B | 2.48B | 3B | 3.8B | 4.55B |
| Gross Margin | 91.9% | 92.7% | 92.8% | 94.9% | 92.5% |
| Research & Development | 945M | 1.08B | 1.93B | 2.01B | 2.78B |
| Selling, General & Admin | 858M | 726M | 968M | 965M | 866M |
| Operating Expenses | 1.8B | 1.81B | 2.9B | 2.97B | 3.64B |
| Depreciation & Amortization | 185M | 170M | 162M | 183M | 249M |
| EBITDA | 971M | 841M | 374M | 903M | 1.41B |
| EBITDA Margin | 35.9% | 31.4% | 11.6% | 22.5% | 28.6% |
| Operating Income | 680M | 678M | 99M | 827M | 908M |
| Operating Margin | 25.2% | 25.3% | 3.1% | 20.6% | 18.5% |
| Interest Income | 2M | 42M | 110M | 116M | 111M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 106M | (7M) | 113M | (107M) | 249M |
| Income Before Tax | 786M | 671M | 212M | 720M | 1.16B |
| Pre-Tax Margin | 29.1% | 25.0% | 6.6% | 18.0% | 23.5% |
| Income Tax Expense | 110M | 147M | (94M) | (72M) | 253M |
| Net Income | 549M | 524M | 306M | 792M | 904M |
| Net Margin | 20.3% | 19.6% | 9.5% | 19.8% | 18.4% |
| EPS (Basic) | 0.54 | 0.51 | 0.30 | 0.75 | 0.85 |
| EPS (Diluted) | 0.54 | 0.51 | 0.29 | 0.75 | 0.85 |
| Weighted Avg Shares | 1.03B | 1.03B | 1.03B | 1.05B | 1.06B |
| Weighted Avg Shares (Diluted) | 1.03B | 1.03B | 1.04B | 1.06B | 1.07B |
Arm Holdings plc American Depositary Shares
NASDAQ:ARM
Intrinsic Alpha fair value
Locked
Current Price
$182.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.